Paul Foulger

Paul Foulger is an experienced finance and business professional with a strong background in the biosciences and diagnostics sectors. Currently serving as Chief Financial Officer at GEN inCode and a Non Executive Director at Penrhos Bio and Autoclenz, Paul has held various leadership roles, including CFO at PredictImmune and NovaBiotics Ltd, and Group Finance Director at EKF Diagnostics. With a diverse portfolio that includes positions on the boards of multiple biotechnology and diagnostics companies, Paul has a keen expertise in financial management and strategic oversight. Paul holds an MBA from the University of Warwick - Warwick Business School.